• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

InterMune

NASDAQ:ITMN

$10.73 $0.54 (5.30%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

InterMune to Sell Actimmune Rights - Analyst Blog

5/22/2012 by Nasdaq

Sequenom's Brief, Wondrous Agreement

5/22/2012 by DailyFinance

Drug Approval! Oh, Wait, We Knew That Already.

5/12/2012 by DailyFinance

Has InterMune Become the Perfect Stock?

5/7/2012 by DailyFinance

Why InterMune Shares Got Crushed

4/27/2012 by DailyFinance

A $5 Million Lottery Ticket

4/18/2012 by DailyFinance

5 of Last Week's Biggest Losers

4/16/2012 by DailyFinance

The Week's Biggest Stock Disappointments

4/15/2012 by DailyFinance

Why Did These Stocks Just Die?

4/10/2012 by DailyFinance

InterMune tumbles on study update

4/9/2012 by MarketWatch

Bad Clinical Trial Trumps Good Acquisition

4/5/2012 by DailyFinance

Investors Pile Into Arena

4/4/2012 by DailyFinance

Investors Faint From FDA Rejection

3/29/2012 by DailyFinance

Will the FDA Approve Chelsea's Northera?

3/27/2012 by DailyFinance

Drug Pricing Takes This Biotech on a Rollercoaster

3/16/2012 by DailyFinance

InterMune Wins Positive Ruling for Esbriet Lung Drug in Germany

3/15/2012 by Minyanville

InterMune Shares Popped: What You Need to Know

3/15/2012 by DailyFinance

Those Europeans Will Approve (Almost) Anything

2/29/2012 by DailyFinance

1 Biotech Back From the Dead

2/28/2012 by DailyFinance

Biotech Investors, Take Note: Margin of Victory Matters

2/24/2012 by DailyFinance

Avoid This Biotech Stock

2/22/2012 by DailyFinance

FDA Concerns Ruin Biotech's Day

2/14/2012 by DailyFinance

InterMune Widens Loss, Sales Dip - Analyst Blog

2/10/2012 by Nasdaq

3 Lessons From the J.P. Morgan Health-Care Confab

1/15/2012 by DailyFinance

The 2 Biotechs Ramping Up Sales

1/10/2012 by DailyFinance

InterMune 4Q Esbriet Sales Snapshot - Analyst Blog

1/9/2012 by Nasdaq

The Week's Top Stock Gainers

1/7/2012 by DailyFinance

Tomorrow's Monster Stock

1/6/2012 by DailyFinance

InterMune Shares Popped: What You Need to Know

1/5/2012 by DailyFinance

Are These Biotech Drug Launches Back on Track?

1/5/2012 by DailyFinance

3 Stock-Moving Binary Events to Watch in 2012

12/31/2011 by DailyFinance

The Worst Health Care Stocks of 2011

12/30/2011 by DailyFinance

5 of Last Week's Biggest Losers

12/19/2011 by DailyFinance

A Fool Looks Back

12/17/2011 by DailyFinance

InterMune Shares Plunged: What You Need to Know

12/16/2011 by DailyFinance

Safety (Still) Trumps Acquisitions in Hep C

12/16/2011 by DailyFinance

InterMune's Shares Got Crushed: What You Need to Know

12/15/2011 by DailyFinance

1 Massive Biotech Bloodbath

12/15/2011 by DailyFinance

The Zacks Analyst Blog Highlights: Gilead Sciences, Pharmasset, Nasdaq Biotechnology ETF, InterMune

11/22/2011 by Nasdaq

Don't Get Too Worked Up Over InterMune's Earnings

11/22/2011 by DailyFinance
See More Articles...